Alzamend Neuro, Inc.
ALZN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001677077
In the last 90 days, Alzamend Neuro, Inc. insiders filed 1 open-market purchase and 1 sale; 12 institutions reported holding it in 13F filings for Q2 2026, worth $3.26M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Alzamend Neuro, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 22 | 21 | −1 |
| Shares | 3.26M | 3.09M | −165.2K (−5.1%) |
| Value | $4.01M | $2.70M | −$1.31M (−32.7%) |
New holders (6)
Institutions that held Alzamend Neuro, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 101,646 | $88.0K | 0.00% |
| Renaissance Technologies LLC | 65,131 | $56.0K | 0.00% |
| Vanguard Group Inc | 60,747 | $53.0K | 0.00% |
| Group One Trading, L.P. | 11,702 | $10.0K | 0.00% |
| Insight Wealth Strategies, LLC | 10,000 | $9.00K | 0.00% |
| Citigroup Inc | 2,000 | $2.00K | 0.00% |
Sold out (7)
Institutions that held Alzamend Neuro, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Marshall Wace, LLP | 124,115 | $154.0K |
| Qube Research & Technologies Ltd | 78,465 | $97.0K |
| Cubist Systematic Strategies, LLC | 37,900 | $47.0K |
| Squarepoint Ops LLC | 19,601 | $24.0K |
| Jane Street Group, LLC | 16,628 | $20.0K |
| Forum Private Client Group LLC | 16,302 | $20.0K |
| Allworth Financial LP | 300 | $0 |